Literature DB >> 9489581

Delirium in dementia.

B Robertsson1, K Blennow, C G Gottfries, A Wallin.   

Abstract

Delirium is a common mental disorder in the elderly with old age being a major risk factor for delirium. Another major risk factor is dementia. The aim of the present study was to identify differences in occurrence of episodes of delirium between the most common dementia diagnoses and the possible importance of age, gender, severity and duration of dementia for the development of delirium. Included in the study were 175 consecutive patients with probable Alzheimer's disease, vascular dementia (VAD) or frontotemporal dementia (FTD) who were admitted to a neuropsychiatric diagnostic unit. There were no significant differences in sex distribution or duration of dementia between the delirious and non delirious patients. The rate of delirium was higher in late onset Alzheimer's disease (LAD) than in early onset Alzheimer's disease (EAD) and FTD. It was also higher in VAD than in EAD. The differences in occurrence of delirium between the diagnostic groups in this sample could not be explained by differences in age. It seems that delirium is more common in brain disorders such as LAD and VAD in which the damage to the brain is more widespread. In the two brain disorders that are predominantly cortical, EAD and FTD, the occurrence of delirium was comparatively low.

Entities:  

Mesh:

Year:  1998        PMID: 9489581     DOI: 10.1002/(sici)1099-1166(199801)13:1<49::aid-gps733>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  11 in total

1.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

2.  Delirium as a disorder of consciousness.

Authors:  Ravi Bhat; Kenneth Rockwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-08       Impact factor: 10.154

Review 3.  Acute confusional States in the elderly--diagnosis and treatment.

Authors:  Stefan Lorenzl; Ingo Füsgen; Soheyl Noachtar
Journal:  Dtsch Arztebl Int       Date:  2012-05-25       Impact factor: 5.594

Review 4.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct.

Authors:  J Bradshaw; M Saling; M Hopwood; V Anderson; A Brodtmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

Review 6.  Current Challenges in the Recognition and Management of Delirium Superimposed on Dementia.

Authors:  Anita Nitchingham; Gideon A Caplan
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-05       Impact factor: 2.570

7.  Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease.

Authors:  Piet Eikelenboom; Jeroen Jm Hoozemans; Rob Veerhuis; Eric van Exel; Annemieke Jm Rozemuller; Willem A van Gool
Journal:  Alzheimers Res Ther       Date:  2012-06-04       Impact factor: 6.982

8.  Cognitive frailty: frontiers and challenges.

Authors:  A J Woods; R A Cohen; M Pahor
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 5.285

9.  Could neutrophil-to-lymphocyte ratio predict mortality in community-dwelling older people with delirium superimposed on dementia?

Authors:  Bilal Katipoglu; Mehmet Ilkin Naharci
Journal:  Aging Clin Exp Res       Date:  2022-03-23       Impact factor: 4.481

10.  Worsening cognitive impairment and neurodegenerative pathology progressively increase risk for delirium.

Authors:  Daniel H J Davis; Donal T Skelly; Carol Murray; Edel Hennessy; Jordan Bowen; Samuel Norton; Carol Brayne; Terhi Rahkonen; Raimo Sulkava; David J Sanderson; J Nicholas Rawlins; David M Bannerman; Alasdair M J MacLullich; Colm Cunningham
Journal:  Am J Geriatr Psychiatry       Date:  2014-08-15       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.